申请人:Davies Huw M.L.
公开号:US20090048329A1
公开(公告)日:2009-02-19
Provided herein are substituted pyrrolidines that demonstrate binding at biogenic amine transporters and can be synthesized by a methodology based on a chiral dirhodium catalyst. Compositions comprising substituted pyrrolidines can be used to treat central nervous system disorders such as schizophrenia.
本文提供了一种替代吡咯烷衍生物,其在生物胺转运体上表现出结合,并可以通过基于手性二铑催化剂的方法合成。包含替代吡咯烷的组合物可用于治疗中枢神经系统疾病,例如精神分裂症。